Wound Care & General Surgery Devices
Producers of advanced wound dressings, negative pressure wound therapy, and surgical stapling and closure products.
- 4
- Verticals
Overview
Wound Care & General Surgery Devices covers producers of advanced wound dressings, negative-pressure wound therapy (NPWT), and surgical stapling and closure products. Advanced wound care and NPWT are led by Smith+Nephew, Solventum (3M spinoff), Convatec, and Mölnlycke, with chronic-wound prevalence driving demand.
Demand is supported by aging, diabetes, and chronic-wound prevalence, and the category combines devices with recurring consumables. It is consolidated and steady-growth, with advanced and biologic wound products the higher-value, faster-growing tier.
Market snapshot
- Market size
- ~$38B
- Growth
- ~2.6%CAGR (2017–22, nominal)
- Companies
- ~1,800
U.S. Census Bureau 2022 CBP/Economic Census, NAICS 339113 (Surgical Appliance & Supplies Manufacturing).
Business model & economics
- Revenue model
- Device and recurring-consumable sales
- Recurring revenue
- High — recurring dressings and consumables
- EBITDA margin
- 18–28%
- Capex intensity
- High
- Aging, diabetes, and chronic-wound prevalence drive demand.
- Advanced and biologic wound products the higher-value tier.
- Devices plus recurring consumables.
M&A deal context
Who’s acquiring
What’s driving deals
- Acquisition of advanced and biologic wound products.
- Chronic-wound prevalence demand.
- Recurring-consumable economics.
Verticals in this segment
- 4.8.13.1Advanced Wound Care Products
Antimicrobial dressings, biological wound care, and wound management products.
- 4.8.13.2Compression & Vascular Therapy
Compression bandaging and venous insufficiency therapy devices.
- 4.8.13.3Negative Pressure Wound Therapy
Wound VAC and negative pressure wound management systems.
- 4.8.13.4Surgical Stapling & Closure
Stapling devices, sutures, and wound closure products.
Find Wound Care & General Surgery Devices acquisition targets
Search Acquisera’s index for companies classified under Wound Care & General Surgery Devices (4.8.13) and build a targeted deal pipeline.
Search companies